Global Founders Capital, the corporate venturing arm of Rocket Internet and backed by the Samwer brothers, has invested an undisclosed amount of capital in a series A round of funding for Traveloka.com, an Indonesia-based flight booking website.
Month: September 2013
Infocom sources deal flow with Fenox
Japan-based IT group Infocom is working with US-based venture capital firm Fenox Venture Capital to bring global IT companies and services to Asia. Fenox will act as a bridge for global start-ups seeking entry to lucrative Asian markets. With this partnership in place, start-ups receiving investment from Fenox VC can then access the expertise of… Continue reading Infocom sources deal flow with Fenox
Daiichi Sankyo plants seed for uni pharma spin-off fund
Japan-based pharmaceutical company, Daiichi Sankyo, and Japan corporate investment unit Mitsubishi UFJ Capital have launched a new open innovation business through the Organization for Small & Medium Enterprises and Regional Innovation (OiDE Fund Investment Limited Partnership). The fund will be operated by Mitsubishi UFJ Capital with combined commitments of YEN750m ($7.5m). Daiichi Sankyo has committed… Continue reading Daiichi Sankyo plants seed for uni pharma spin-off fund
Dell Ventures widens focus
Dell Ventures, whose parent company Dell is being taken private by its founder Michael Dell, is reported to have widened its investment focus.
Tesco’s Dunnhumby launches retail tech fund
Dunnhumby, a UK-based retail analytics company, which is a subsidiary of UK-based supermarket Tesco, has launched Dunnhumby Ventures, a seed-stage investment fund focusing on retail technology. Dave Balter, global head of investments at Dunnhumby, said: “We are looking for retail’s game changers.” Dunnhumby Ventures, which will be based in Boston, USA, plans to invest $100,000… Continue reading Tesco’s Dunnhumby launches retail tech fund
PatientSafe heads for Singapore
PatientSafe Solutions, a US-based healthcare technology company whose PatientTouch mobile workflow and communications system for caregivers combines software with customized Apple hardware, has closed a strategic investment from Economic Development Board Investments (EDBI), the corporate investment arm of the Singapore Economic Development Board, bringing its total series C funding to $27m. The series C round,… Continue reading PatientSafe heads for Singapore
Bertelsmann goes back to UniversityNow
Existing investor Bertelsmann and First Analysis Corp lead $19m series C funding for social venture providing affordable degrees.
Intel-backed BlueData raises $15m
Big data private cloud developer BlueData raises $15m series B funding led by Ignition Partners and including support from Intel Capital.
Chevron launches CTV Fund V
Chevron Technology Ventures, the venture capital investment arm of Chevron, has launched CTV Fund V, a $90m venture capital fund to invest in early- to mid-stage companies and in limited partnership funds. The companies should be developing emerging technologies that have the potential to improve Chevron’s oil and gas base business performance or create opportunities… Continue reading Chevron launches CTV Fund V
FireEye serves up hot IPO
Cyber attack protector launches on Nasdaq with its shares starting at double its initial public offering price.
Rocket Fuel rings Nasdaq bell
Nokia-backed digital advertising platform Rocket Fuel sees IPO price double on first day.
Chevron extends Veros funding
Chevron Technology Ventures extends series A funding to $8m for industrial asset monitoring company.
Google gives AngelList wings
Entrepreneur funding site AngelList raises $24m from 146 investors, including top tier investor Google Ventures.
Pharmstandard extends Protagonist’s B funding
Protagonist Therapeutics, a US-based biotechnology company which is developing oral peptide therapeutics, has secured $4m additional series B funding from Pharmstandard International S.A., a holding company of Russia-based pharmaceutical OJSC Pharmstandard, bringing the total series B funding raised to $18m. The new funding is in addition to the $14m series B financing previously announced in… Continue reading Pharmstandard extends Protagonist’s B funding